New Delhi, May 9 -- Dr Reddy's Laboratories Q4FY25 results: Dr Reddy's Laboratories, the country's leading India-based pharmaceutical company, released its March quarter performance on Friday, May 9, reporting a 22% year-on-year jump in consolidated net profit to Rs.1,594 crore, beating Street estimates of Rs.1,491 crore.

Revenue also exceeded estimates, coming in at Rs.8,506 crore compared to Rs.7,083 crore in the same period last year, marking a growth of 20%.

On the operating front, EBITDA came in at Rs.2,975 crore, marking a 58.9% improvement compared to Rs.1,872 crore in Q4FY23, while margins expanded by 510 basis points to reach 29.1%. In the same quarter of the previous fiscal year, the company had reported a margin of 24%.

(mor...